The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infection

T L Katzenstein; O Kirk; C Pedersen; J D Lundgren; H Nielsen; N Obel; C Nielsen; Lars Reinhardt Mathiesen; J Gerstoft

doi:10.1086/315746

The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infection

T L Katzenstein
, O Kirk
, C Pedersen
, J D Lundgren
, H Nielsen
, N Obel
, C Nielsen
, Lars Reinhardt Mathiesen
, J Gerstoft

26 Citationer (Scopus)

Abstract

The Danish Protease Inhibitor (PI) Study has enrolled 318 human immunodeficiency virus (HIV)-infected, PI-naive patients for the purpose of comparing 3 PI-containing regimens for the treatment of HIV infection. The regimens include 2 nucleoside analogues in combination with indinavir (Idr), ritonavir (Rtv), or Rtv and saquinavir (Rtv/Sqv). Similar percentages of patients in the 3 study arms achieved reduced levels (

Originalsprog	Engelsk
Tidsskrift	Journal of Infectious Diseases
Vol/bind	182
Udgave nummer	3
Sider (fra-til)	744-50
Antal sider	6
ISSN	0022-1899
DOI	https://doi.org/10.1086/315746
Status	Udgivet - 2000

Adgang til dokumentet

10.1086/315746

http://www.ncbi.nlm.nih.gov/entrez/query.fcgi?cmd=Retrieve&db=pubmed&dopt=Abstract&list_uids=10950767

Citationsformater

Katzenstein, T. L., Kirk, O., Pedersen, C., Lundgren, J. D., Nielsen, H., Obel, N., Nielsen, C., Mathiesen, L. R., & Gerstoft, J. (2000). The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infection. Journal of Infectious Diseases, 182(3), 744-50. https://doi.org/10.1086/315746

The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infection. / Katzenstein, T L; Kirk, O; Pedersen, C et al.
I: Journal of Infectious Diseases, Bind 182, Nr. 3, 2000, s. 744-50.

Publikation: Bidrag til tidsskrift › Tidsskriftartikel › Forskning › peer review

Katzenstein, TL, Kirk, O, Pedersen, C, Lundgren, JD, Nielsen, H, Obel, N, Nielsen, C, Mathiesen, LR & Gerstoft, J 2000, 'The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infection', Journal of Infectious Diseases, bind 182, nr. 3, s. 744-50. https://doi.org/10.1086/315746

@article{756dbfe4dcb74851a747866fae7185a7,

title = "The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infection",

abstract = "The Danish Protease Inhibitor (PI) Study has enrolled 318 human immunodeficiency virus (HIV)-infected, PI-naive patients for the purpose of comparing 3 PI-containing regimens for the treatment of HIV infection. The regimens include 2 nucleoside analogues in combination with indinavir (Idr), ritonavir (Rtv), or Rtv and saquinavir (Rtv/Sqv). Similar percentages of patients in the 3 study arms achieved reduced levels (",

keywords = "Adolescent, Adult, CD4 Lymphocyte Count, Drug Therapy, Combination, Female, HIV Infections, HIV Protease Inhibitors, HIV-1, Humans, Indinavir, Male, Ritonavir, Saquinavir, Viral Load",

author = "Katzenstein, \{T L\} and O Kirk and C Pedersen and Lundgren, \{J D\} and H Nielsen and N Obel and C Nielsen and Mathiesen, \{Lars Reinhardt\} and J Gerstoft",

year = "2000",

doi = "10.1086/315746",

language = "English",

volume = "182",

pages = "744--50",

journal = "Journal of Infectious Diseases",

issn = "0022-1899",

publisher = "Oxford University Press",

number = "3",

}

TY - JOUR

T1 - The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infection

AU - Katzenstein, T L

AU - Kirk, O

AU - Pedersen, C

AU - Lundgren, J D

AU - Nielsen, H

AU - Obel, N

AU - Nielsen, C

AU - Mathiesen, Lars Reinhardt

AU - Gerstoft, J

PY - 2000

Y1 - 2000

N2 - The Danish Protease Inhibitor (PI) Study has enrolled 318 human immunodeficiency virus (HIV)-infected, PI-naive patients for the purpose of comparing 3 PI-containing regimens for the treatment of HIV infection. The regimens include 2 nucleoside analogues in combination with indinavir (Idr), ritonavir (Rtv), or Rtv and saquinavir (Rtv/Sqv). Similar percentages of patients in the 3 study arms achieved reduced levels (

AB - The Danish Protease Inhibitor (PI) Study has enrolled 318 human immunodeficiency virus (HIV)-infected, PI-naive patients for the purpose of comparing 3 PI-containing regimens for the treatment of HIV infection. The regimens include 2 nucleoside analogues in combination with indinavir (Idr), ritonavir (Rtv), or Rtv and saquinavir (Rtv/Sqv). Similar percentages of patients in the 3 study arms achieved reduced levels (

KW - Adolescent

KW - Adult

KW - CD4 Lymphocyte Count

KW - Drug Therapy, Combination

KW - Female

KW - HIV Infections

KW - HIV Protease Inhibitors

KW - HIV-1

KW - Humans

KW - Indinavir

KW - Male

KW - Ritonavir

KW - Saquinavir

KW - Viral Load

U2 - 10.1086/315746

DO - 10.1086/315746

M3 - Journal article

C2 - 10950767

SN - 0022-1899

VL - 182

SP - 744

EP - 750

JO - Journal of Infectious Diseases

JF - Journal of Infectious Diseases

IS - 3

ER -

The danish protease inhibitor study: a randomized study comparing the virological efficacy of 3 protease inhibitor-containing regimens for the treatment of human immunodeficiency virus type 1 infection

Abstract

Adgang til dokumentet

Fingeraftryk

Citationsformater